Several trials of cholinesterase inhibitors (ChEIs) have been conducted in individuals with amnestic type MCI, which is likely due to underlying AD (Tricco et al., 2013; Matsunaga et al., 2019). The gene discussed is BCHE; the disease is Alzheimer disease.